April 23, 2018 / 11:52 AM / 7 months ago

BRIEF-Pfizer: EU Approves Mylotarg With Chemotherapy To Treat Acute Myeloid Leukemia

April 23 (Reuters) - Pfizer Inc:

* MYLOTARG™ APPROVED IN THE EU FOR THE TREATMENT OF PREVIOUSLY UNTREATED, DE NOVO, CD33-POSITIVE ACUTE MYELOID LEUKEMIA IN COMBINATION WITH CHEMOTHERAPY

* PFIZER - APPROVAL OF MYLOTARG BASED ON DATA FROM INVESTIGATOR-LED, PHASE 3 RANDOMIZED, OPEN-LABEL STUDY IN PREVIOUSLY UNTREATED, DE NOVO PATIENTS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below